GDRX Investors Have Opportunity to Join GoodRx Holdings, Inc. Securities Fraud Investigation with the Schall Law Firm

Published 6 months ago via Business Wire

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of GoodRx Holdings, Inc. (“GoodRx” or “the Company”) (NASDAQ: GDRX) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. GoodRX earned a significant portion of its total prescription transactions revenue from Kroger stores, despite the grocery chain representing less than 5% of the pharmacies accepting its discounts. The Company was at risk of Kroger unilaterally cutting off or changing its policies on accepting its discounts. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about GoodRX, investors suffered damages.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Contacts